ArticleFrontiers in pharmacology2020

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients.

Jia-Qi Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.